Evidence map›Paper›PMID 20644207›Full record

Trial reportNicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco2010

Changes in smoking expectancies in abstinent, reducing, and non-abstinent participants during a pharmacological trial for smoking cessation.

Andrea H Weinberger, Sherry A McKee, Tony P George

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it, 17 citations in OpenAlex.

  1. Antidepressants for smoking cessation.The Cochrane database of systematic reviews · 2020
    Pooled it
  2. Antidepressants for smoking cessation.The Cochrane database of systematic reviews · 2014
    Pooled it
  3. Predicting quit attempts among homeless smokers seeking cessation treatment: an ecological momentary assessment study.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2014
    Trial
  4. Review
  5. Antidepressants for smoking cessation.The Cochrane database of systematic reviews · 2023
    Review
  6. Article
  7. Article
  8. Article
  9. Gender differences in negative reinforcement smoking expectancies.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2015
    Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Andrea H WeinbergerDivision of Substance Abuse, Department of Psychiatry, Yale University School of Medicine, 34 Park Street, SAC, Room S-211, New Haven, CT 06519, USA. andrea.weinberger@yale.edu
Sherry A McKee
Tony P George
Yale University · USCentre for Addiction and Mental Health · CA

Funding

SUBSTANCE ABUSEK12DA000167 · NIDA · YALE UNIVERSITY · PI STEPHANIE S O'MALLEY, Marc N Potenza · 1991 to 2026
$17.7M
Tobacco Dependence &Risk Factors for Treatment FailureP50AA015632 · NIAAA · YALE UNIVERSITY · PI O'MALLEY, STEPHANIE S · 2004 to 2008
$9.2M
Selegiline for Smoking CessationR01DA015757 · NIDA · YALE UNIVERSITY · PI POTENZA, MARC N · 2004 to 2007
$1.4M
Modeling Stress-Precipitated Smoking Lapse for Medication Development (9 of 14)RL1DA024857 · NIDA · YALE UNIVERSITY · PI MCKEE, SHERRY ANN · 2007 to 2011
$1.3M
CIHRNIAAA NIH HHS P50-AA015632NIDA NIH HHS K12 DA000167NIDA NIH HHS K12-DA000167NIDA NIH HHS R01 DA015757NIDA NIH HHS R01-DA015757NIDA NIH HHS RL1 DA024857NIDA NIH HHS RL1DA024857
6 · The paper itself

Abstract

introductionSmoking expectancies are related to smoking consumption and predict smoking cessation. Little is known about whether expectancies change during smoking treatments, consistent with changes in smoking behavior. This study examined reported changes in smoking beliefs during an 8-week smoking cessation trial, which evaluated the safety and efficacy of the monoamine oxidase B inhibitor selegiline hydrochloride versus placebo.

methodsParticipants were classified as "Quit" (n = 18), "Reduced" (n = 34), or "Not Quit" (n = 49) by 7-day point prevalence abstinence at the end of treatment. Expectancies were assessed at randomization, 1 week after the target quit date, and at the end of treatment.

resultsBeliefs about smoking assessed prior to the quit attempt were not associated with cessation outcomes. Participants who quit smoking reported a reduction in expectations that smoking would reduce negative affect, boredom, and cravings, and facilitate social interactions, while participants who did not quit smoking reported an increase in Negative Social Impression beliefs. There were gender differences in beliefs related to Negative Affect Reduction, Negative Physical Feelings, Social Facilitation, and Cravings and significant Gender X Smoking Status interactions for Health Risk and Weight Control beliefs. There were no significant effects of medication on expectancies. DISCUSSION: Baseline expectancies were not associated with abstinence outcomes; however, expectancies changed over time with changes in smoking, and the greatest changes were seen with smoking abstinence. Information about the relationship between smoking beliefs and behaviors may be used to enhance or tailor smoking cessation treatments.

Indexed as

Attitude to HealthAdultFemaleFollow-Up StudiesHealth BehaviorHumansMaleMiddle AgedMonoamine Oxidase InhibitorsMotivationPatient Acceptance of Health CareSelegilineSelf EfficacySmokingSmoking CessationSurveys and QuestionnairesMonoamine Oxidase InhibitorsSelegiline

Identifiers

PMID20644207
PMCPMC2928936
OpenAlexW2106959167

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.